|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 122.75 INR | -1.60% |
|
-4.40% | -17.26% |
| 09/07 | Camlin Fine Sciences Ownership in Vinpai Tops 95% After Cash Tender Offer | MT |
| 06/07 | Camlin Fine Sciences Limited completed the acquisition o 11.00049 % stake in Vinpai SAS for ?1.8 million. | CI |
Company Valuation: Camlin Fine Sciences Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 17,824 | 21,899 | 20,006 | 14,946 | 31,552 | 23,579 | - | - |
| Change | - | 22.86% | -8.65% | -25.29% | 111.1% | -25.27% | - | - |
| Enterprise Value (EV) | 17,824 | 21,899 | 20,006 | 14,946 | 31,552 | 23,579 | 23,579 | 23,579 |
| Change | - | 22.86% | -8.65% | -25.29% | 111.1% | -25.27% | 0% | 0% |
| P/E | 38x | 30.6x | 37.3x | -16x | -20.9x | 67.3x | 30.7x | 15.1x |
| PBR | - | - | 2.44x | 1.73x | - | 1.86x | 2.1x | 1.94x |
| PEG | - | 1.3x | -1.5x | 0x | -0.5x | -1x | 0x | 0x |
| Capitalization / Revenue | 1.5x | 1.55x | 1.19x | 0.93x | - | 1.08x | 1.11x | 1x |
| EV / Revenue | 0x | 0x | 0x | 0x | - | 1.32x | 1.11x | 1x |
| EV / EBITDA | 0x | 0x | 0x | 0x | - | 17.9x | 9.37x | 7.11x |
| EV / EBIT | 0x | 0x | 0x | -0x | - | 36.8x | 13.7x | 9.7x |
| EV / FCF | 0x | -0x | -0x | 0x | -0x | 35.3x | 288x | 13.8x |
| FCF Yield | 1.88% | -3.12% | -4.67% | 5.25% | -0.5% | 1.32% | 0.35% | 7.26% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 3.68 | 4.56 | 3.41 | -5.58 | -8.03 | 1.44 | 4 | 8.15 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 11,871 | 14,121 | 16,816 | 16,131 | - | 17,233 | 21,331 | 23,616 |
| EBITDA 1 | 1,819 | 1,528 | 2,053 | 739.2 | - | 1,069 | 2,517 | 3,318 |
| EBIT 1 | 1,376 | 968.4 | 1,428 | -46.91 | - | 359.6 | 1,726 | 2,430 |
| Net income 1 | 509.6 | 606.8 | 521.1 | -927.5 | - | 276.3 | 765 | 1,568 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 139.80 | 139.50 | 127.35 | 89.25 | 167.90 | 122.75 | 122.75 | 122.75 |
| Nbr of stocks (in thousands) | 1,27,498 | 1,56,984 | 1,57,093 | 1,67,465 | 1,87,921 | 1,92,087 | - | - |
| Announcement Date | 28/05/21 | 19/05/22 | 22/05/23 | 20/05/24 | 23/05/25 | 26/05/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 2455x | - | - | - | 24Cr | |
| 35x | 4.94x | 19.89x | 1.07% | 7.68TCr | |
| 29.44x | 4.62x | 19.73x | 2.16% | 3.92TCr | |
| 22x | 2.66x | 13.73x | 2.42% | 3.15TCr | |
| 15.31x | 1.47x | 8.93x | 2.05% | 2.65TCr | |
| 35.43x | 8.69x | 26.44x | 2.59% | 2.2TCr | |
| 10.85x | 2.8x | 5.92x | 3.69% | 1.99TCr | |
| 26.12x | 2.72x | 11.1x | 1.63% | 1.83TCr | |
| 12.2x | 2.43x | 5.23x | 1.34% | 1.42TCr | |
| 22.96x | 2.74x | 12.59x | 1.49% | 1.39TCr | |
| Average | 266.43x | 3.67x | 13.73x | 2.05% | 2.63TCr | |
| Weighted average by Cap. | 28.59x | 4.01x | 15.71x | 1.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CAMLINFINE Stock
- Valuation Camlin Fine Sciences Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
